Clinical Trials Announced, $SNOVF:OTC/$KBEV:TSX-V
Post# of 250601
Koios Launches Clinical Trials to Study Efficacy of Their Nootropic Smart Drinks. They are also in the process of obtaining an OTCQB listing to expand investment opportunities for US investors.
Insert-tag-herehttps://www.stockwatch.com/News/Item.aspx…